Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Gilbert PE, Delis DC.

J Int Neuropsychol Soc. 2019 May 7:1-6. doi: 10.1017/S1355617719000407. [Epub ahead of print]

PMID:
31060638
2.

Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3.

Graves LV, Simone S, Williams M, Courville T, Mattson SN, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

Appl Neuropsychol Adult. 2019 May 6:1-8. doi: 10.1080/23279095.2019.1605993. [Epub ahead of print]

PMID:
31060389
3.

Early versus late MCI: Improved MCI staging using a neuropsychological approach.

Edmonds EC, McDonald CR, Marshall A, Thomas KR, Eppig J, Weigand AJ, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 May;15(5):699-708. doi: 10.1016/j.jalz.2018.12.009. Epub 2019 Feb 6.

PMID:
30737119
4.

Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.

Weissberger GH, Gollan TH, Bondi MW, Nation DA, Hansen LA, Galasko D, Salmon DP.

J Alzheimers Dis. 2019;67(1):291-302. doi: 10.3233/JAD-180351.

PMID:
30636736
5.

Alzheimer's disease and the processing of uncertainty during choice task performance: Executive dysfunction within the Hick-Hyman law.

Korthauer LE, Salmon DP, Festa EK, Galasko D, Heindel WC.

J Clin Exp Neuropsychol. 2019 May;41(4):380-389. doi: 10.1080/13803395.2018.1564813. Epub 2019 Jan 11.

PMID:
30632903
6.

Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.

Thomas KR, Eppig JS, Weigand AJ, Edmonds EC, Wong CG, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Apr;15(4):561-569. doi: 10.1016/j.jalz.2018.10.008. Epub 2019 Jan 11.

PMID:
30610833
7.

Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease.

Smirnov DS, Galasko D, Hansen LA, Edland SD, Brewer JB, Salmon DP.

Neurobiol Aging. 2019 Mar;75:169-177. doi: 10.1016/j.neurobiolaging.2018.11.015. Epub 2018 Nov 22.

PMID:
30579145
8.

Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.

Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA.

J Alzheimers Dis. 2018;66(4):1539-1548. doi: 10.3233/JAD-180789.

PMID:
30412501
9.

Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment.

Edmonds EC, Weigand AJ, Thomas KR, Eppig J, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW.

J Int Neuropsychol Soc. 2018 Sep;24(8):842-853. doi: 10.1017/S1355617718000486.

10.

New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

J Int Neuropsychol Soc. 2018 Sep;24(8):833-841. doi: 10.1017/S1355617718000474. Epub 2018 Aug 16.

11.

Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.

Thomas KR, Edmonds EC, Eppig J, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;64(1):195-204. doi: 10.3233/JAD-180229.

PMID:
29865077
12.

Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.

Zlatar ZZ, Muniz MC, Espinoza SG, Gratianne R, Gollan TH, Galasko D, Salmon DP.

J Alzheimers Dis. 2018;63(3):949-956. doi: 10.3233/JAD-170865.

13.

Word-list intrusion errors predict progression to mild cognitive impairment.

Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative*.

Neuropsychology. 2018 Feb;32(2):235-245. doi: 10.1037/neu0000413.

14.

Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults.

Sundermann EE, Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Rubin LH, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;61(3):1163-1178. doi: 10.3233/JAD-170425.

PMID:
29332038
15.

Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study.

Edmonds EC, Ard MC, Edland SD, Galasko DR, Salmon DP, Bondi MW.

Alzheimers Dement (N Y). 2017 Dec 1;4:11-18. doi: 10.1016/j.trci.2017.11.001. eCollection 2018.

16.

Alzheimer's Disease: Past, Present, and Future.

Bondi MW, Edmonds EC, Salmon DP.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X. Review.

17.

Potential implications of practice effects in Alzheimer's disease prevention trials.

Jacobs DM, Ard MC, Salmon DP, Galasko DR, Bondi MW, Edland SD.

Alzheimers Dement (N Y). 2017 Sep 19;3(4):531-535. doi: 10.1016/j.trci.2017.08.010. eCollection 2017 Nov.

18.

Bilingual language intrusions and other speech errors in Alzheimer's disease.

Gollan TH, Stasenko A, Li C, Salmon DP.

Brain Cogn. 2017 Nov;118:27-44. doi: 10.1016/j.bandc.2017.07.007. Epub 2017 Jul 25.

19.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

20.

Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults.

Zlatar ZZ, Muniz M, Galasko D, Salmon DP.

J Gerontol B Psychol Sci Soc Sci. 2018 Sep 20;73(7):1198-1202. doi: 10.1093/geronb/gbw207.

PMID:
28329816
21.

Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.

Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH.

J Neurosci. 2017 Feb 15;37(7):1675-1684. doi: 10.1523/JNEUROSCI.3047-16.2016. Epub 2016 Dec 30.

22.

Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.

Edmonds EC, Bangen KJ, Delano-Wood L, Nation DA, Furst AJ, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2016 Nov;22(10):978-990.

23.

Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.

Cronin P, McCarthy MJ, Lim ASP, Salmon DP, Galasko D, Masliah E, De Jager PL, Bennett DA, Desplats P.

Alzheimers Dement. 2017 Jun;13(6):689-700. doi: 10.1016/j.jalz.2016.10.003. Epub 2016 Nov 22.

24.

Total recognition discriminability in Huntington's and Alzheimer's disease.

Graves LV, Holden HM, Delano-Wood L, Bondi MW, Woods SP, Corey-Bloom J, Salmon DP, Delis DC, Gilbert PE.

J Clin Exp Neuropsychol. 2017 Mar;39(2):120-130. doi: 10.1080/13803395.2016.1204993. Epub 2016 Jul 21.

25.

The effect of interference on temporal order memory in individuals with Parkinson's disease.

DeFord NE, Landy KM, Pirogovsky-Turk E, Van Etten EJ, Graves LV, Salmon DP, Filoteo JV, Gilbert PE.

Brain Cogn. 2016 Aug;107:30-6. doi: 10.1016/j.bandc.2016.05.008. Epub 2016 Jun 28.

26.

Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease.

Mitolo M, Hamilton JM, Landy KM, Hansen LA, Galasko D, Pazzaglia F, Salmon DP.

J Int Neuropsychol Soc. 2016 Jul;22(6):609-19. doi: 10.1017/S1355617716000436. Epub 2016 May 25.

27.

"Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria.

Edmonds EC, Delano-Wood L, Jak AJ, Galasko DR, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2016 Mar 31;52(2):685-91. doi: 10.3233/JAD-150986.

28.

Visual search in Dementia with Lewy Bodies and Alzheimer's disease.

Landy KM, Salmon DP, Filoteo JV, Heindel WC, Galasko D, Hamilton JM.

Cortex. 2015 Dec;73:228-39. doi: 10.1016/j.cortex.2015.08.020. Epub 2015 Sep 21.

29.

Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.

Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(1):231-42. doi: 10.3233/JAD-150128.

30.

Motion discrimination in dementia with Lewy bodies and Alzheimer disease.

Landy KM, Salmon DP, Galasko D, Filoteo JV, Festa EK, Heindel WC, Hansen LA, Hamilton JM.

Neurology. 2015 Oct 20;85(16):1376-82. doi: 10.1212/WNL.0000000000002028. Epub 2015 Sep 23.

31.

Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease.

Salmon DP, Heindel WC, Hamilton JM, Vincent Filoteo J, Cidambi V, Hansen LA, Masliah E, Galasko D.

Neuropsychologia. 2015 Aug;75:548-55. doi: 10.1016/j.neuropsychologia.2015.07.014. Epub 2015 Jul 14.

32.

Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.

Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, Edland SD, Salmon DP, Galasko DR, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative Investigators.

JAMA Neurol. 2015 May;72(5):546-53. doi: 10.1001/jamaneurol.2014.4477.

33.

Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.

Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA; Alzheimer’s Disease Cooperative Study.

JAMA Neurol. 2015 Apr;72(4):446-54. doi: 10.1001/jamaneurol.2014.3375. Erratum in: JAMA Neurol. 2015 May;72(5):608.

34.

Repetition priming and cortical arousal in healthy aging and Alzheimer's disease.

Kane AE, Festa EK, Salmon DP, Heindel WC.

Neuropsychologia. 2015 Apr;70:145-55. doi: 10.1016/j.neuropsychologia.2015.02.024. Epub 2015 Feb 18.

35.

The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline.

Banks SJ, Raman R, He F, Salmon DP, Ferris S, Aisen P, Cummings J.

Dement Geriatr Cogn Dis Extra. 2014 Dec 18;4(3):509-16. doi: 10.1159/000357775. eCollection 2014 Sep-Dec.

36.

Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2014 Sep;20(8):836-47. doi: 10.1017/S135561771400068X. Epub 2014 Aug 26.

37.

Interactive effects of vascular risk burden and advanced age on cerebral blood flow.

Bangen KJ, Nation DA, Clark LR, Harmell AL, Wierenga CE, Dev SI, Delano-Wood L, Zlatar ZZ, Salmon DP, Liu TT, Bondi MW.

Front Aging Neurosci. 2014 Jul 7;6:159. doi: 10.3389/fnagi.2014.00159. eCollection 2014.

38.

Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease.

Bangen KJ, Nation DA, Delano-Wood L, Weissberger GH, Hansen LA, Galasko DR, Salmon DP, Bondi MW.

Alzheimers Dement. 2015 Apr;11(4):394-403.e1. doi: 10.1016/j.jalz.2013.12.025. Epub 2014 Jul 9.

39.

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, Weiner M, Aisen PS; Australian Imaging, Biomarkers, and Lifestyle Flagship Study of Ageing; Alzheimer’s Disease Neuroimaging Initiative; Alzheimer’s Disease Cooperative Study.

JAMA Neurol. 2014 Aug;71(8):961-70. doi: 10.1001/jamaneurol.2014.803.

40.

Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Edmonds EC, Delano-Wood L, Clark LR, Jak AJ, Nation DA, McDonald CR, Libon DJ, Au R, Galasko D, Salmon DP, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Apr;11(4):415-24. doi: 10.1016/j.jalz.2014.03.005. Epub 2014 May 22.

41.

Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP.

J Alzheimers Dis. 2014;42(1):275-89. doi: 10.3233/JAD-140276.

42.

Which language declines more? longitudinal versus cross-sectional decline of picture naming in bilinguals with Alzheimer's disease.

Ivanova I, Salmon DP, Gollan TH.

J Int Neuropsychol Soc. 2014 May;20(5):534-46. doi: 10.1017/S1355617714000228. Epub 2014 Apr 11.

43.

The A4 study: stopping AD before symptoms begin?

Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, Aisen P.

Sci Transl Med. 2014 Mar 19;6(228):228fs13. doi: 10.1126/scitranslmed.3007941.

44.

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.

Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT.

Alzheimers Dement. 2014 Sep;10(5):571-81. doi: 10.1016/j.jalz.2013.09.004. Epub 2014 Jan 7.

PMID:
24411134
45.

The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease.

Mitolo M, Salmon DP, Gardini S, Galasko D, Grossi E, Caffarra P.

J Alzheimers Dis. 2014;39(4):823-32. doi: 10.3233/JAD-131403.

46.

Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults.

Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR.

Neurology. 2013 Dec 3;81(23):2024-7. doi: 10.1212/01.wnl.0000436935.47657.78. Epub 2013 Nov 13.

47.

Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults.

Lineweaver TT, Bondi MW, Galasko D, Salmon DP.

Am J Psychiatry. 2014 Feb;171(2):201-8. doi: 10.1176/appi.ajp.2013.12121590.

48.

Abnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease.

Olichney JM, Pak J, Salmon DP, Yang JC, Gahagan T, Nowacki R, Hansen L, Galasko D, Kutas M, Iragui-Madoz VJ.

Cogn Neurosci. 2013;4(3-4):143-51. doi: 10.1080/17588928.2013.838945. Epub 2013 Oct 4.

49.

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Chang YL, Fennema-Notestine C, Holland D, McEvoy LK, Stricker NH, Salmon DP, Dale AM, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 May;10(3):336-48. doi: 10.1016/j.jalz.2013.05.1763. Epub 2013 Jul 27.

50.

Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.

Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PS.

Neuropsychology. 2013 Jul;27(4):391-401. doi: 10.1037/a0032707.

Supplemental Content

Loading ...
Support Center